Article
Mesoblast asks for trading halt as PDUFA date slides by. What's up?
Rating:
0.0
Views:
112
Likes:
1
Library:
1
Everything was all lined up for Mesoblast's Wednesday PDUFA date regarding its acute graft-versus-host disease candidate remestemcel-L, or Ryoncil. But with no word in any direction on any FDA actions, the biotech is preparing its stock for the delayed ruling. Mesoblast $MESO has asked the Australian stock exchange to place
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value